Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1).

Methodology/Principal Findings: Abrogation of galectin-3 biosynthesis in multilayered cultures of human corneal epithelial cells using siRNA, and in galectin-3 null mice, resulted

In this study, we examined the expression pattern of PLC e 1 in human gastric tissues including normal, atrophic gastritis, and tumor tissues, and made a hypothesis on the role of PLC

We investigated expression levels of MMP-2, MMP-9, COX-2, RANK/RANKL and SOCS-1 in rat intestinal tissues from the negative control, MTX , and MTX- OLM 5 mg/kg groups

(41) observed that the expression of MMP-2, MMP-7, MMP-9, TIMP-2, and TIMP-3 in ovarian cancer is higher compared with normal ovarian tissues and benign ovarian tumors.. They have

Purposes: To evaluate the effects of nalbuphine 1% on the expression of me- talloproteinase 1 (MMP-1), metalloproteinase 9 (MMP-9), and opioid growth factor (OGF) in rabbit

In 7 gastric cancer cell lines, the expressions of Rac1 were higher than in gastric mucosal epithelial cell line (GES-1) [43], which was coincided with the phenomenon we found

mRNA ( A ) and protein ( B ) expression of fi broblast growth factor receptor 1 (FGFR1) in normal human GES-1 cells and fi ve gastric cancer cell lines measured by RT-qPCR and

Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.. Initiation of human